Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 203184
Company: IMPAX LABS INC
Company: IMPAX LABS INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PYRIDOSTIGMINE BROMIDE | PYRIDOSTIGMINE BROMIDE | 180MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/15/2015 | ORIG-1 | Approval |
Label is not available on this site. |
PYRIDOSTIGMINE BROMIDE
TABLET, EXTENDED RELEASE;ORAL; 180MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
MESTINON | PYRIDOSTIGMINE BROMIDE | 180MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | Yes | AB | 011665 | BAUSCH |
PYRIDOSTIGMINE BROMIDE | PYRIDOSTIGMINE BROMIDE | 180MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 204737 | ALVOGEN |
PYRIDOSTIGMINE BROMIDE | PYRIDOSTIGMINE BROMIDE | 180MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 203184 | IMPAX LABS INC |
PYRIDOSTIGMINE BROMIDE | PYRIDOSTIGMINE BROMIDE | 180MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 205464 | RISING |